Nine drugs included in the list were made by manufacturers from Himachal Pradesh. All medicines listed for not being of standard quality were of well-known manufacturing companies.
The finding came after the FDA inspector collected random samples during inspections. One of the drugs in the list is for children and two are antibiotic medicines. A few are vitamin tablets and syrups.
Most of the drugs were found to have less amount of Hi-Fextferrous Ascorbate than required, and folic acid tablets, Pre Pro Kid, Lactobacil Plus, Xime Clav dry syrup, Rebal D tablets, Serkas Suspension, Pesolen-5 and Encarmin syrup were in the list for this reason.
Two drugs on the list do not comply with IP requirements and have hardly 10 per cent of molecular content of what is printed on the medicine.
According to data provided by the FDA, the list has nine drugs from Himachal Pradesh, one each from Madhya Pradesh and Rajasthan and two from Uttarakhand.
The FDA also found one drug on which the manufacturer’s address, batch number, manufacturing date and expiry date were not printed, for which action is will be taken against the manufacturer.
The pharma companies which made these medicines were identified by the FDA as Associated Biotech, Digital Vision, Galpha Laboratories, Rahul Pharmaceuticals, Swiss Garnier Life Sciences, Ultratech Pharmaceuticals, Unispeed Pharmaceuticals from Himachal Pradesh, Numech Healthcare from Madhya Pradesh, Baba Ayurved Pharmacy from Rajasthan, Eskag Pharma Pvt Ltd and G S Pharmaceuticals Pvt Ltd from Uttarakhand.